Tech Company Financing Transactions
Sangart Funding Round
On 4/4/2007, Sangart raised $50 million in Series F funding from Leucadia National Corp.
Transaction Overview
Company Name
Announced On
4/4/2007
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series F
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
6175 Lusk Blvd
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Sangart, Inc. is a biopharmaceutical company focused on the research, development and commercialization of oxygen transport agents.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian O'Callaghan
Chief Financial Officer
David Renas
Chief Medical Officer
Frank Booth
Chief Operating Officer
Don Brown
Chief Scientific Officer
Kenneth Burhop
VP - Human Resources
Kristine Figueroa
VP - Regulatory Affairs
Carmen Betancourt-Riche
Browse more venture capital transactions:
Prev: 4/4/2007: Surface Logix venture capital transaction
Next: 4/4/2007: Firm58 venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs